SAN FRANCISCO, April 18, 2017 /PRNewswire/ --
The global structural heart devices market is expected toreach USD 9.1 billion by 2025, based on a new report by Grand View Research, Inc. The market is expected to witness an exponential growth over the next 8 years due to the rapid increase in cardiovascular conditions and increasing
(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )
The defects are mostly present at birth, thereby directly affecting the under-5 mortality rate of a country. Therefore, rigorous actions are being undertaken by various government bodies across the globe to increase access to treatment. The Centers for Disease Control and Prevention have a public action plan to efficient management of cardiac conditions.
In addition, other organizations are working on improving the scenario for structural heart diseases treatment. For instance, in November 2016, the Cardiovascular Research Foundation (CRF) announced a launch of a journal focusing on diagnosis and treatment of structural heart defects. It was titled Structural Heart: The Journal of the Heart Team and is expected to be launched in May 2017. This is expected to trigger research & development activities along with capital invested in this field, resulting in technological advancements.
Browse full research report with TOC on "Structural Heart Devices Market By Type (Surgical Aortic Valve Replacement [SAVR], Transcatheter Aortic Valve Replacement [TAVR], Mitral Repair (Annuloplasty), Left Atrial Appendage Closure [LAAC]), By Region, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/structural-heart-devices-market
Further key findings from the report suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the structural heart devices market by type and region:
Read Our Blog: Structural Heart Devices Market: Increasing Diseases Prevalence to Boost the Market by 2025
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: +1-888-202-9519 Email: [email protected]
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Hand hygiene is a simple and affordable technique to prevent infections.
Erythropoietin is a hormone secreted by kidneys in response to low oxygen levels in tissues ...
Local anesthesia is a type of anesthesia generally used to block pain sensation only in a specific ...View All